A0A2I2Z0P2 (A0A2I2Z0P2_GORGO) Gorilla gorilla gorilla (Western lowland gorilla)
Peroxisome proliferator-activated receptor alpha UniProtKBInterProSTRINGInteractive Modelling
468 aa; Sequence (Fasta) ;
3 identical sequences: Homo sapiens: Q07869, F1D8S4; Pongo abelii: H2P4S5
Available Structures
64 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structural basis for iloprost as a dual PPARalpha/delta agonist |
Heteromer Q07869; Q86YN6; | 100.0 | 1×IL2; | |||
| Structure of PPARalpha with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid |
Heteromer Q07869; Q15788; | 100.0 | 1×ET1; | |||
| X-ray structure of human PPARalpha ligand binding domain-fenofibric acid-SRC1 coactivator peptide c… |
Heteromer Q07869; Q15788; | 100 | 2×F5A; | |||
| X-ray structure of human PPARalpha ligand binding domain-clofibric acid-SRC1 coactivator peptide co… |
Heteromer Q07869; Q15788; | 100 | 2×E0O; | |||
| the crystal structure of the human PPARaplpha ligand binding domain in complex with a a-hydroxyimin… |
Heteromer Q07869; Q15788; | 99.63 | 1×MMB; | |||
| X-ray structure of human PPARalpha ligand binding domain-bezafibrate-SRC1 coactivator peptide co-cr… |
Heteromer Q07869; Q15788; | 100.0 | 1×PEM; | |||
| Novel natural PPARalpha agonist with a unique binding mode |
Heteromer Q07869; Q15788; | 100.0 | 1×SAU; | |||
| X-ray structure of human PPAR alpha ligand binding domain-lanifibranor-SRC1 coactivator peptide co-… |
Heteromer Q07869; Q15788; | 100.0 | ||||
| Crystal structure of the human PPAR-alpha ligand-binding domain in complex with an antagonist GW647… |
Heteromer Q07869; Q9Y618; | 100 | 1×471; | |||
| X-ray structure of human PPARalpha ligand binding domain-pemafibrate-SRC1 coactivator peptide co-cr… |
Heteromer Q07869; Q15788; | 100.0 | 1×P7F; 1×GOL; | |||
| X-ray structure of human PPARalpha ligand binding domain-eicosapentaenoic acid (EPA)-SRC1 coactivat… |
Heteromer Q07869; Q15788; | 100.0 | 1×EPA; 1×GOL; | |||
| X-ray structure of human PPARalpha ligand binding domain-intrinsic fatty acid (E. coli origin)-SRC1… |
Heteromer Q07869; Q15788; | 100.0 | 1×PLM; 1×GOL; | |||
| X-ray structure of human PPAR alpha ligand binding domain-elafibranor-SRC1 coactivator peptide co-c… |
Heteromer Q07869; Q15788; | 100.0 | 1×GOL; 1×MUO; | |||
| a crystal structure of PPAR alpha bound with SRC1 peptide and GW735 |
Heteromer Q07869; Q15788; | 100 | 1×735; | |||
| X-ray structure of human PPARalpha ligand binding domain-GW7647-SRC1 coactivator peptide co-crystal… |
Heteromer Q07869; Q15788; | 100.0 | 1×2VN; | |||
| Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diab… |
Heteromer Q07869; Q15788; | 100.0 | 1×RO7; | |||
| Design and biological evaluation of novel, balanced dual PPARa/g agonists |
Heteromer Q07869; Q15788; | 100.0 | 1×CTM; | |||
| The 2.5 Angstrom resolution crystal structure of the human PPARalpha ligand binding domain bound wi… |
Heteromer Q07869; Q15788; | 100 | 1×544; | |||
| Structure of PPARalpha-LBD/pemafibrate/SRC1 peptide |
Heteromer Q07869; Q15788; | 100.0 | 2×P7F; | |||
| Ternary complex of hPPARalpha ligand binding domain, 17-oxoDHA and a SRC1 peptide |
Heteromer Q07869; Q15788; | 99.62 | 1×4M5; | |||
| Human PPAR alpha ligand binding domain in complex with a synthetic agonist (compound A) |
Heteromer Q07869; Q9UBK2; | 100 | 1×T02; | |||
| Human PPAR alpha ligand binding domain in complex with a synthetic agonist (compound B) |
Heteromer Q07869; Q9UBK2; | 100.0 | 1×T06; | |||
| Crystal structure of peroxisome proliferator-activatedeceptor alpha (PPARalpha) complex with N-3-((… | homo-2-mer | 100.0 | 2×NKS; | |||
| Crystal structure of peroxisome proliferator-activatedeceptor alpha (PPARalpha) complex with N-3-((… | homo-2-mer | 100.0 | 2×7HA; | |||
| HUMAN PPAR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH APHM6 OBTAINED BY SOAKING | homo-2-mer | 100.0 | 2×HW3; | |||
| HUMAN PPAR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH YN4pai OBTAINED BY SOAKING | homo-2-mer | 100.0 | 2×HVX; | |||
| HUMAN PPAR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH APHM6 OBTAINED BY COCRYSTALLIZATION | homo-2-mer | 100.0 | 2×HW3; | |||
| HUMAN PPAR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH TIPP703 OBTAINED BY SOAKING | homo-2-mer | 100.0 | 2×S44; | |||
| CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN FROM HUMAN PPAR-ALPHA IN COMPLEX WITH THE AGONIST AZ… | monomer | 100.0 | 1×NA; 1×AZ2; 1×CPQ; | |||
| X-ray structure of human PPARalpha ligand binding domain-intrinsic fatty acid (E. coli origin) co-c… | monomer | 100.0 | 1×GOL; 1×PLM; | |||
| X-ray structure of human PPARalpha ligand binding domain-eicosapentaenoic acid (EPA) co-crystals ob… | monomer | 100.0 | 1×GOL; 1×EPA; | |||
| X-ray structure of human PPARalpha ligand binding domain-tetradecylthioacetic acid (TTA) co-crystal… | monomer | 100.0 | 1×GOL; 1×T4T; | |||
| X-ray structure of human PPARalpha ligand binding domain-arachidonic acid co-crystals obtained by d… | monomer | 100 | 1×GOL; 1×ACD; | |||
| X-ray structure of human PPARalpha ligand binding domain-stearic acid co-crystals obtained by delip… | monomer | 100.0 | 1×GOL; 1×STE; | |||
| X-ray structure of human PPARalpha ligand binding domain-pemafibrate co-crystals obtained by delipi… | monomer | 100.0 | 1×GOL; 1×P7F; | |||
| X-ray structure of human PPARalpha ligand binding domain-tetradecylthioacetic acid (TTA) co-crystal… | monomer | 100.0 | 1×GOL; 1×T4T; | |||
| X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by delipidatio… | monomer | 100.0 | 1×GOL; 1×2VN; | |||
| X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by cross-seedi… | monomer | 100.0 | 1×GOL; 1×2VN; | |||
| X-ray structure of human PPARalpha ligand binding domain-pemafibrate co-crystals obtained by cross-… | monomer | 100.0 | 1×GOL; 1×P7F; | |||
| X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by soaking | monomer | 100.0 | 1×2VN; 1×GOL; | |||
| X-ray structure of human PPARalpha ligand binding domain-ciprofibrate co-crystals obtained by delip… | monomer | 100 | 1×GOL; 2×C5F; | |||
| X-ray structure of human PPAR alpha ligand binding domain-seladelpar co-crystals obtained by cross-… | monomer | 100.0 | 1×GOL; 1×KKB; | |||
| X-ray structure of human PPARalpha ligand binding domain-saroglitazar co-crystals obtained by delip… | monomer | 100.0 | 1×EWR; | |||
| X-ray structure of human PPARalpha ligand binding domain-fenofibric acid co-crystals obtained by de… | monomer | 100 | 2×F5A; | |||
| Crystal Structure of PPARalpha ligand binding domain with BMS-631707 | monomer | 100.0 | 1×CPQ; 1×REW; | |||
| X-ray structure of human PPARalpha ligand binding domain-saroglitazar co-crystals obtained by soaki… | monomer | 100.0 | 1×EWR; | |||
| X-ray structure of human PPARalpha ligand binding domain-GW9662-gemfibrozil co-crystals obtained by… | monomer | 100 | 2×GW9; | |||
| X-ray structure of human PPARalpha ligand binding domain-GW9662-clofibric acid co-crystals obtained… | monomer | 100 | 3×GW9; | |||
| X-ray structure of human PPARalpha ligand binding domain-GW9662-ciprofibrate co-crystals obtained b… | monomer | 100 | 3×GW9; 1×C5F; | |||
| X-ray structure of human PPARalpha ligand binding domain-GW9662-fenofibric acid co-crystals obtaine… | monomer | 100 | 3×GW9; 1×F5A; | |||
| X-ray structure of human PPARalpha ligand binding domain-5,8,11,14-eicosatetraynoic Acid (ETYA) co-… | monomer | 100.0 | 1×GOL; 1×ITY; | |||
| X-ray structure of human PPARalpha ligand binding domain-palmitic acid co-crystals obtained by deli… | monomer | 100.0 | 1×GOL; 1×PLM; | |||
| X-ray structure of human PPARalpha ligand binding domain-5,8,11,14-eicosatetraynoic acid (ETYA) co-… | monomer | 100.0 | 1×GOL; 1×ITY; | |||
| X-ray structure of human PPARalpha ligand binding domain-pemafibrate co-crystals obtained by soaking | monomer | 100.0 | 1×GOL; 1×P7F; | |||
| X-ray structure of human PPARalpha ligand binding domain-oleic acid co-crystals obtained by delipid… | monomer | 100.0 | 1×GOL; 1×OLA; | |||
| Human PPAR alpha ligand binding domain in complex with a synthetic agonist APHM13 | monomer | 100.0 | 1×13M; | |||
| X-ray structure of human PPARalpha ligand binding domain-Wy14643 co-crystals obtained by co-crystal… | monomer | 100.0 | 2×WY1; | |||
| Crystal structure of the complex PPARalpha/AL26-29 | monomer | 100.0 | 1×65W; | |||
| X-ray structure of human PPARalpha ligand binding domain-Wy14643 co-crystals obtained by soaking | monomer | 100 | 2×WY1; | |||
| Human PPAR alpha ligand binding domain in complex with a synthetic agonist TIPP703 | monomer | 100.0 | 1×S44; | |||
| X-ray structure of human PPARalpha ligand binding domain-Wy14643 co-crystals obtained by delipidati… | monomer | 100.0 | 2×WY1; | |||
| Crystal structure of PPAR alfa Ligand Binding Domain in complex with the ligand LBB78 | monomer | 100.0 | 1×WUE; | |||
| Structural basis for GL479 a dual Peroxisome Proliferator-Activated Receptor alpha agonist | monomer | 100.0 | 1×Y1N; | |||
| Structure of PPARalpha in complex with WY14643 | monomer | 100 | 1×EDO; 2×WY1; | |||
7 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3dzy.1.B | monomer | 0.70 | 1×ZN; | 64.96 | ||
| 7wnh.4.A | monomer | 0.58 | 1×ZN; | 25.98 | ||
| 7wnh.2.A | monomer | 0.58 | 1×ZN; | 25.98 | ||
| 4iqr.2.A | monomer | 0.53 | 1×ZN; | 28.21 | ||
| 4iqr.2.B | monomer | 0.52 | 1×ZN; | 28.21 | ||
| 3dzu.1.A | monomer | 0.52 | 1×ZN; | 34.81 | ||
| 4nqa.2.A | monomer | 0.51 | 1×ZN; | 34.94 | ||